Table 4.
Post-procedural adverse events according to CTCAE v 5.0 based on 183 M-PHP procedures
| Adverse events | Grade 3 [n (%)] | Grade 4 [n(%)] | Grade 5 [n(%)] |
|---|---|---|---|
| Hematological | |||
| Anemia | 13 (7.1) | 1 (0.5) | |
| Leucopenia | 16 (8.7) | 28 (15.3) | |
| Thrombocytopenia | 26 (14.2) | 26 (14.2) | |
| Hepatic | |||
| Increased AST | 12 (6.6) | 2 (1.1) | |
| Increased ALT | 10 (5.4) | 2 (1.1) | |
| Increased bilirubin | 4 (2.2) | ||
| Gastrointestinal | |||
| Gastric ulcer | 1 (0.5) | ||
| Vascular | |||
| Pulmonary embolism | 5 (2.7) | ||
| Cardiac | |||
| Cardiac ischemia | 1 (0.5) | ||
| Metabolism and nutrition | |||
| Hyperglycemia | 1 (0.5) | ||
| Tumor lysis syndrome | 1 (0.5) | ||
| Renal/urinary | |||
| Acute kidney injury | 3 (1.6) | ||
| Infections | |||
| Vulvar infection | 1 (0.5) | ||
| Sepsis | 1 (0.5) | ||
| Febrile neutropenia | 5 (2.7) | ||
| Others | 1 (0.5) | ||
| Nervous system | |||
| Vasovagal reaction | 2 (1.1) | ||
| Stroke | 5 (2.7) | ||
| General disorders | |||
| Fatigue | 1 (0.5) | ||
| Death | 2 (1.1) | ||
AST aspartate aminotransferase, ALT alanine aminotransferase